Spinal mechanisms of NPY analgesia - PubMed
Review
Spinal mechanisms of NPY analgesia
Peter A Smith et al. Peptides. 2007 Feb.
Abstract
We review previously published data, and present some new data, indicating that spinal application of neuropeptide Y (NPY) reduces behavioral and neurophysiological signs of acute and chronic pain. In models of acute pain, early behavioral studies showed that spinal (intrathecal) administration of NPY and Y2 receptor agonists decrease thermal nociception. Subsequent neurophysiological studies indicated that Y2-mediated inhibition of excitatory neurotransmitter release from primary afferent terminals in the substantia gelatinosa may contribute to the antinociceptive actions of NPY. As with acute pain, NPY reduced behavioral signs of inflammatory pain such as mechanical allodynia and thermal hyperalgesia; however, receptor antagonist studies indicate an important contribution of spinal Y1 rather than Y2 receptors. Interestingly, Y1 agonists suppress inhibitory synaptic events in dorsal horn neurons (indeed, well known mu-opioid analgesic drugs produce similar cellular actions). To resolve the behavioral and neurophysiological data, we propose that NPY/Y1 inhibits the spinal release of inhibitory neurotransmitters (GABA and glycine) onto inhibitory neurons, e.g. disinhibition of pain inhibition, resulting in hyporeflexia. The above mechanisms of Y1- and Y2-mediated analgesia may also operate in the setting of peripheral nerve injury, and new data indicate that NPY dose-dependently inhibits behavioral signs of neuropathic pain. Indeed, neurophysiological studies indicate that Y2-mediated inhibition of Ca(2+) channel currents in dorsal root ganglion neurons is actually increased after axotomy. We conclude that spinal delivery of Y1 agonists may be of use in the treatment of chronic inflammatory pain, and that the use of Y1 and Y2 agonists in neuropathic pain warrants further consideration.
Similar articles
-
Moran TD, Colmers WF, Smith PA. Moran TD, et al. J Neurophysiol. 2004 Dec;92(6):3266-75. doi: 10.1152/jn.00096.2004. Epub 2004 Aug 4. J Neurophysiol. 2004. PMID: 15295007
-
Wiley RG, Lemons LL, Kline RH 4th. Wiley RG, et al. Neuroscience. 2009 Jun 16;161(1):139-47. doi: 10.1016/j.neuroscience.2008.12.017. Epub 2008 Dec 24. Neuroscience. 2009. PMID: 19138726
-
Mahinda TB, Taylor BK. Mahinda TB, et al. Physiol Behav. 2004 Feb;80(5):703-11. doi: 10.1016/j.physbeh.2003.12.007. Physiol Behav. 2004. PMID: 14984805
-
NPY and pain as seen from the histochemical side.
Hökfelt T, Brumovsky P, Shi T, Pedrazzini T, Villar M. Hökfelt T, et al. Peptides. 2007 Feb;28(2):365-72. doi: 10.1016/j.peptides.2006.07.024. Epub 2007 Jan 17. Peptides. 2007. PMID: 17234301 Review.
-
Neuropeptide tyrosine and pain.
Brumovsky P, Shi TS, Landry M, Villar MJ, Hökfelt T. Brumovsky P, et al. Trends Pharmacol Sci. 2007 Feb;28(2):93-102. doi: 10.1016/j.tips.2006.12.003. Epub 2007 Jan 11. Trends Pharmacol Sci. 2007. PMID: 17222466 Review.
Cited by
-
Intondi AB, Dahlgren MN, Eilers MA, Taylor BK. Intondi AB, et al. Pain. 2008 Jul 15;137(2):352-365. doi: 10.1016/j.pain.2007.09.016. Epub 2007 Oct 31. Pain. 2008. PMID: 17976913 Free PMC article.
-
Waber-Wenger B, Forterre F, Kuehni-Boghenbor K, Danuser R, Stein JV, Stoffel MH. Waber-Wenger B, et al. Histochem Cell Biol. 2014 Oct;142(4):433-47. doi: 10.1007/s00418-014-1218-x. Epub 2014 Apr 20. Histochem Cell Biol. 2014. PMID: 24748503
-
Neuropeptide Y and posttraumatic stress disorder.
Sah R, Geracioti TD. Sah R, et al. Mol Psychiatry. 2013 Jun;18(6):646-55. doi: 10.1038/mp.2012.101. Epub 2012 Jul 17. Mol Psychiatry. 2013. PMID: 22801411 Free PMC article. Review.
-
Bacon A, Kerr NC, Holmes FE, Gaston K, Wynick D. Bacon A, et al. J Neurosci. 2007 Jun 13;27(24):6573-80. doi: 10.1523/JNEUROSCI.1596-07.2007. J Neurosci. 2007. PMID: 17567818 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous